This study systematically compares small extracellular vesicles (sEVs) derived from four neural cell lines, revealing how cellular origin shapes vesicle biophysical properties and proteomic cargo. Distinct, lineage‐specific signatures linked to neuronal, astrocytic, and microglial functions are identified, highlighting the importance of cell source ...
Muhammad Waqas Salim +4 more
wiley +1 more source
Neurological manifestations of lysosomal storage diseases. [PDF]
Elendu C +15 more
europepmc +1 more source
Advancing the Research and Development of Enzyme Replacement Therapies for Lysosomal Storage Diseases. [PDF]
Puhl AC, Ekins S.
europepmc +1 more source
Feasibility and efficacy of the forced oscillation technique in patients with lysosomal storage diseases. [PDF]
Alblooshi A +3 more
europepmc +1 more source
Secondary Mitochondrial Dysfunction as a Cause of Neurodegenerative Dysfunction in Lysosomal Storage Diseases and an Overview of Potential Therapies. [PDF]
Stepien KM +5 more
europepmc +1 more source
Extracellular Vesicles as Tools for Crossing the Blood-Brain Barrier to Treat Lysosomal Storage Diseases. [PDF]
Lerussi G +6 more
europepmc +1 more source
Prenatal Delivery of Enzyme Replacement Therapy to Fetuses Affected by Early-Onset Lysosomal Storage Diseases. [PDF]
Borges B +8 more
europepmc +1 more source
Marine‐derived type I collagen is extracted from Scyliorhinus canicula skin and characterized by physicochemical and morphological analyses. The collagen exhibits excellent biocompatibility, promotes wound healing, reduces inflammatory mediators, and inhibits melanogenesis.
Marwa Rejeb +6 more
wiley +1 more source
Reply—Nonimmune Hydrops Fetalis and Lysosomal Storage Diseases
Ozge Surmeli-Onay, Ayse Korkmaz
doaj +1 more source
Treatment Beliefs Reflect Unmet Clinical Needs in Lysosomal Storage Diseases: An Opportunity for a Patient-Centered Approach. [PDF]
Corazolla EM +4 more
europepmc +1 more source

